SPRINGWORKS THERAPEUTICS INC (SWTX) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:SWTX • US85205L1070

46.99 USD
+0.01 (+0.02%)
At close: Jun 30, 2025
46.98 USD
-0.01 (-0.02%)
After Hours: 6/30/2025, 8:00:01 PM
Buy % Consensus

51

ChartMill assigns a Buy % Consensus number of 51% to SWTX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 53.33. This target is 13.5% above the current price.
  • SWTX was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about SWTX.
  • In the previous month the buy percentage consensus was at a similar level.
  • SWTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
SWTX Historical Analyst RatingsSWTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -69 -63 -57 -51 -45 -39 -33 -27 -21 -15 -9 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 46.9947.4747.9453.3388.20 - 1.02% 2.02% 13.50% 87.70%
SWTX Current Analyst RatingSWTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-05-12 Guggenheim Reiterate Neutral -> Neutral
2025-04-30 HC Wainwright & Co. Downgrade Buy -> Neutral
2025-04-29 TD Cowen Downgrade Buy -> Hold
2025-04-29 Guggenheim Downgrade Buy -> Neutral
2025-04-28 Barclays Downgrade Overweight -> Equal-Weight
2025-02-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-12 Wedbush Reiterate Outperform -> Outperform
2025-02-12 Evercore ISI Group Maintains Outperform -> Outperform
2025-02-12 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-08 Guggenheim Maintains Buy -> Buy
2024-11-20 Evercore ISI Group Initiate Outperform
2024-11-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-09-04 JP Morgan Maintains Overweight -> Overweight
2024-08-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-06 JP Morgan Maintains Overweight -> Overweight
2024-03-06 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-29 Barclays Maintains Overweight -> Overweight
2024-02-26 Wedbush Maintains Outperform -> Outperform
2024-01-25 Barclays Maintains Overweight -> Overweight
2023-11-29 Goldman Sachs Maintains Buy -> Buy
2023-11-29 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-28 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-09 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-24 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 HC Wainwright & Co. Maintains Buy -> Buy

SPRINGWORKS THERAPEUTICS INC / SWTX FAQ

What do analysts expect the price target to be for SPRINGWORKS THERAPEUTICS INC (SWTX)?

11 analysts have analysed SWTX and the average price target is 53.33 USD. This implies a price increase of 13.5% is expected in the next year compared to the current price of 46.99.


What is the consensus rating for SPRINGWORKS THERAPEUTICS INC (SWTX) stock?

The consensus rating for SPRINGWORKS THERAPEUTICS INC (SWTX) is 50.9091 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


How many analysts cover SPRINGWORKS THERAPEUTICS INC (SWTX) stock?

The number of analysts covering SPRINGWORKS THERAPEUTICS INC (SWTX) is 11.